Journal
MOLECULAR INTERVENTIONS
Volume 6, Issue 5, Pages 273-+Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mi.6.5.9
Keywords
-
Categories
Funding
- NIDA NIH HHS [DA 15723, DA 03774, DA 10566] Funding Source: Medline
Ask authors/readers for more resources
The abuse liability of a drug is closely related to its ability to maintain self-administration behavior in laboratory subjects. But how do researchers gauge the reinforcing value of a self-administered drug in the preclinical laboratory? One approach is to determine the preference for that drug, that is, the allocation of behavior to drug taking, when alternative reinforcers are concurrently available. Careful analyses of such choice behavior in laboratory subjects can lead to a scientific understanding of the pharmacological and behavioral determinants of the reinforcing strength of a drug and, ultimately, to a more useful preclinical evaluation of abuse liability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available